Medifast, Inc. (MED)
- Previous Close
31.88 - Open
32.05 - Bid --
- Ask --
- Day's Range
31.71 - 32.65 - 52 Week Range
30.95 - 109.52 - Volume
297,141 - Avg. Volume
378,545 - Market Cap (intraday)
353.78M - Beta (5Y Monthly) 1.15
- PE Ratio (TTM)
3.57 - EPS (TTM)
9.10 - Earnings Date Apr 29, 2024
- Forward Dividend & Yield 6.60 (20.33%)
- Ex-Dividend Date Sep 18, 2023
- 1y Target Est
37.50
Medifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.
medifastinc.com634
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: MED
Performance Overview: MED
Trailing total returns as of 4/18/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MED
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MED
Valuation Measures
Market Cap
353.78M
Enterprise Value
225.75M
Trailing P/E
3.57
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.33
Price/Book (mrq)
1.76
Enterprise Value/Revenue
0.21
Enterprise Value/EBITDA
1.62
Financial Highlights
Profitability and Income Statement
Profit Margin
9.27%
Return on Assets (ttm)
25.24%
Return on Equity (ttm)
55.77%
Revenue (ttm)
1.07B
Net Income Avi to Common (ttm)
99.42M
Diluted EPS (ttm)
9.10
Balance Sheet and Cash Flow
Total Cash (mrq)
150.04M
Total Debt/Equity (mrq)
10.93%
Levered Free Cash Flow (ttm)
106.22M
Research Analysis: MED
Analyst Price Targets
Fair Value
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Research Reports: MED
MED: Lowering target price to $34.00
MEDIFAST INC has an Investment Rating of HOLD; a target price of $34.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingNeutralPrice TargetMED: Lowering target price to $36.00
MEDIFAST INC has an Investment Rating of HOLD; a target price of $36.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingNeutralPrice TargetMED: Lowering target price to $37.00
MEDIFAST INC has an Investment Rating of HOLD; a target price of $37.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingNeutralPrice TargetMED: Raising target price to $39.00
MEDIFAST INC has an Investment Rating of HOLD; a target price of $39.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingNeutralPrice Target